KVC in the News
Advocates regroup after Sanders blocks pediatric PRV reauthorization
Next chance to revive rare pediatric disease priority review vouchers coming soon
Steven Usdin, 1.2.2025
STAT News: September 12, 2024 — A rare disease program, portrayed as both lifeline and pharma handout, is set to expire
Nature Medicine, April 2022 — How to Correct the Market for Children’s Cancer Drugs, by Nancy Goodman
The Awkward Truth About Trump, Musk, and Kids With Cancer, Daily Beast March 2025
Regulatory News The Cancer Letter March 17, 2025
Political petulance, complacency halt pediatric priority review program, BIOCENTURY January 8, 2025
https://www.thebulwark.com/p/elon-musk-killed-budget-deal-children-cancer-funding-collateral-damage
https://www.nytimes.com/live/2024/12/20/us/government-shutdown-trump-news?smid=nytcore-ios-share&referringSource=articleShare
https://cancerletter.com/the-cancer-letter/20190329_5b/
https://www.washingtonpost.com/opinions/ruth-marcus-out-of-tragedy-some-hope/2012/07/03/gJQAzX6dLW_story.html
https://cancerletter.com/the-cancer-letter/20190329_5b/
https://cancerletter.com/the-cancer-letter/20190329_5b/
https://cancerletter.com/guest-editorial/20190308_5/
https://www.statnews.com/2024/12/20/pediatric-cancer-research-cut-from-gop-spending-bill-backlash-swift/
https://www.nytimes.com/live/2024/12/20/us/government-shutdown-trump-news?smid=nytcore-ios-share&referringSource=articleShare
https://www.newsweek.com/pediatric-cancer-community-devastated-funds-removed-spending-bill-2004417
Federal Register: September 19, 2024 — FDA Sets New Priority Review User Fee Rate for FY 2025: $2,482,446
Blog: September 23, 2024 — U.S. House of Representatives Passes Give Kids a Chance Act, including the Creating Hope Reauthorization Act
September 21, 2024 — Climb the Hill Day
How to Correct the Market for Children’s Cancer Drugs, by Nancy Goodman
Podcast Episode from Help and Hope Happen Here interview with Nancy Goodman
